Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Vanderbilt-Ingram Cancer Center · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
blastoid variant mantle cell lymphoma, recurrent chronic lymphocytic leukemia, recurrent follicular lymphoma, recurrent hodgkin lymphoma, recurrent mantle cell lymphoma, refractory chronic lymphocytic leukemia, refractory follicular lymphoma, refractory hodgkin lymphoma, refractory mantle cell lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 840174
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.